{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T19:03:42Z","timestamp":1771700622982,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T00:00:00Z","timestamp":1153440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2006,10,17]]},"DOI":"10.1007\/s10654-006-9023-z","type":"journal-article","created":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T07:05:09Z","timestamp":1153379109000},"page":"545-549","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002"],"prefix":"10.1007","volume":"21","author":[{"given":"Miriam","family":"Gerlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambros","family":"Uchtenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,21]]},"reference":[{"key":"9023_CR1","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1002\/hep.510360401","volume":"36","author":"MJ Alter","year":"2002","unstructured":"Alter MJ, 2002; Prevention of spread of hepatitis C Hepatology 36: S 93\u2013S98","journal-title":"Hepatology"},{"key":"9023_CR2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s001030170002","volume":"6","author":"E Schreier","year":"2001","unstructured":"Schreier E, H\u00f6hne M, 2001; Hepatitis C \u2013 Epidemiologie und Pr\u00e4vention Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 6: 554\u2013561","journal-title":"Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz"},{"key":"9023_CR3","first-page":"1587","volume":"89","author":"PJ Grob","year":"2000","unstructured":"Grob PJ, Negro F, Renner EL, 2000; im Namen der Schweizer Experten f\u00fcr Virale Hepatitiden (SEVHEP) Hepatitis C-Virus-Infektion. \u00fcbersicht. Praxis 89: 1587\u20131604","journal-title":"Hepatitis C-Virus-Infektion. \u00dcbersicht. Praxis"},{"key":"9023_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1386-6532(02)00116-6","volume":"26","author":"GJ Dore","year":"2003","unstructured":"Dore GJ, Law M, MacDonald M, Kaldor JM, 2003; Epidemiology of hepatitis C virus infection in Australia J Clinical Virol 26: 171\u2013184","journal-title":"J\u2423Clinical Virol"},{"key":"9023_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2893.2002.00339.x","volume":"9","author":"C Mathei","year":"2002","unstructured":"Mathei C, Buntinx F, Van Damme P, 2002; Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: A systematic review J Viral Hepat 9: 157\u2013173","journal-title":"J\u2423Viral Hepat"},{"key":"9023_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1024603517136","volume":"18","author":"M Backmund","year":"2003","unstructured":"Backmund M, Meyer K, W\u00e4chtler M, Eichenlaub D, 2003; Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity Eur J Epidemio 18: 563\u2013568","journal-title":"Eur J Epidemio"},{"key":"9023_CR7","doi-asserted-by":"crossref","unstructured":"Steffen T, Christen S, Bl\u00e4ttler R, Gutzwiller F und das PROVE Team. Infectious diseases and public health: Risk-taking behavior during participating in the Swiss programme for a medical prescription of narcotics (PROVE). Substance Use & Misuse 2001; 36(1&2): 72\u201389","DOI":"10.1081\/JA-100000229"},{"key":"9023_CR8","volume-title":"Die medizinische und soziale Betreuung in der Heroingest\u00fctzten Behandlung","author":"R Bl\u00e4ttler","year":"2000","unstructured":"Bl\u00e4ttler R, Kaufmann B, Nieuwenboom W, Gschwend P, Steffen T, Uchtenhagen A, 2000; Die medizinische und soziale Betreuung in der Heroingest\u00fctzten Behandlung Schlussbericht des Instituts f\u00fcr Suchtforschung Z\u00fcrich"},{"key":"9023_CR9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00002030-199815000-00018","volume":"12","author":"B Broers","year":"1998","unstructured":"Broers B, Junet C, Bourquin M, D\u00e9glon JJ, Perrin L, Hirschel B, 1998; Prevalence and incidence rate of HIV, hepatitits B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995 AIDS 12: 2059\u20132066","journal-title":"AIDS"},{"issue":"6","key":"9023_CR10","first-page":"390","volume":"44","author":"M Holbach","year":"1998","unstructured":"Holbach M, Fr\u00f6sner GG, Donnerbauer E, Dittmeier E, Holbach B, 1998; Pr\u00e4valenz von hepatitismarkern der typen A, B, C und assoziiertes risikoverhalten unter patienten nach intraven\u00f6sem drogenkonsum Sucht 44(6): 390\u2013398","journal-title":"Sucht"},{"issue":"6","key":"9023_CR11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","volume":"26","author":"K Stark","year":"1997","unstructured":"Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I, 1997; History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin Int J Epidemiol 26(6): 1359\u20131366","journal-title":"Int J Epidemiol"},{"key":"9023_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001940050111","volume":"9","author":"F Fehlauer","year":"1999","unstructured":"Fehlauer F, Koops A, Lockmann F, et al. 1999; Pr\u00e4valenz von Hepatitis B, Hepatitis C und HIV-Infektionen bei Drogentodesf\u00e4llen in Hamburg (1985\u20131997) unter Ber\u00fccksichtigung von epidemiologischen, forensischen und morphologischen Aspekten Rechtsmedizin 9: 205\u2013209","journal-title":"Rechtsmedizin"},{"issue":"1","key":"9023_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.91.1.38","volume":"91","author":"VD Hope","year":"2001","unstructured":"Hope VD, Judd A, Hickman M, et al., 2001; Prevalence of hepatitis C among injecting drug users in England and Wales: Is harm reduction working? Am J Public Health 91(1): 38\u201342","journal-title":"Am J Public Health"},{"key":"9023_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","volume":"32","author":"AS M\u00e5nsson","year":"2000","unstructured":"M\u00e5nsson AS, Moestrup T, Nordenfelt E, Widell A, 2000; Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program Scand J Infect Dis 32: 253\u2013258","journal-title":"Scand J Infect Dis"},{"key":"9023_CR15","volume-title":"Bet\u00e4ubungsmittelverschreibung an Heroinabh\u00e4ngige","author":"A Uchtenhagen","year":"2000","unstructured":"Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Bl\u00e4ttler R, Pfeifer S, 2000; Bet\u00e4ubungsmittelverschreibung an Heroinabh\u00e4ngige Wichtigste Resultate der Schweizerischen Kohortenstudie Basel; Karger"},{"issue":"3","key":"9023_CR16","first-page":"293","volume":"165","author":"JJ Ochnio","year":"2001","unstructured":"Ochnio JJ, Patrick D, Ho M, Talling DN, Dobsen SR, 2001; Past infection with hepatitis A virus among Vancouver street youth, injecting drug users and men who have sex with men: implications for vaccinating programs The Can Med Assoc J 165(3): 293\u2013300","journal-title":"The Can Med Assoc J"},{"issue":"3","key":"9023_CR17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/513757","volume":"25","author":"SA Villano","year":"1997","unstructured":"Villano SA, Nelson KE, Vlahoy D, Purcell RH, Saah AJ, Thomas DL, 1997; Hepatitis A among homosexual men and injection drug users: More evidence for vaccination Clin Infect Dis 25(3): 726\u2013728","journal-title":"Clin Infect Dis"},{"key":"9023_CR18","first-page":"62","volume-title":"Pr\u00e4vention und Intervention von Infektionskrankheiten in der heroingest\u00fctzten Behandlung [Dissertation]","author":"C Baumann","year":"1999","unstructured":"Baumann C, 1999; Pr\u00e4vention und Intervention von Infektionskrankheiten in der heroingest\u00fctzten Behandlung [Dissertation] Medizinische Fakult\u00e4t der Universit\u00e4t Z\u00fcrich Z\u00fcrich, Schweiz 62 pp"},{"key":"9023_CR19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1046\/j.1360-0443.2001.961217878.x","volume":"96","author":"PA Cook","year":"2001","unstructured":"Cook PA, Mc Veigh J, Syed Q, Mutton K, Bellis M, 2001; Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment Addiction 96: 1787\u20131797","journal-title":"Addiction"},{"issue":"1","key":"9023_CR20","first-page":"71","volume":"4","author":"TL Lamagni","year":"2001","unstructured":"Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON, 2001; Failure to vaccinate current injecting drug users against hepatitis B in England and Wales Commun Dis Public Health 4(1): 71\u201372","journal-title":"Commun Dis Public Health"},{"key":"9023_CR21","unstructured":"BAG (Bundesamt f\u00fcr Gesundheit). Empfehlungen zur Hepatitis-B-Impfung. Erg\u00e4nzung zum Supplementum II vom Dezember 1997. Bulletin 36 vom 31.08.1998. Bern: 1998"},{"key":"9023_CR22","unstructured":"BAG (Bundesamt f\u00fcr Gesundheit). Empfehlungen zur kombinierten Hepatitis-A-und Hepatitis-B-Impfung. Bulletin 3 vom 27.01.1997. Bern: 1997"},{"key":"9023_CR23","unstructured":"EMCDDA (European Monitoring Centres for Drug and Drug Addiction. 2004 Jahresbericht \u00fcber den Stand der Drogenproblematik in der EU und in Norwegen. URL: http:\/\/ annualreport.emcdda.eu.int\/download\/ar2004-de.pdf, Lisboa: 2004"},{"issue":"2","key":"9023_CR24","first-page":"82","volume":"6","author":"NS Crowcroft","year":"2003","unstructured":"Crowcroft NS, 2003; Hepatitis A virus infections in injecting drug users Commun Dis Public Health 6(2): 82\u201384","journal-title":"Commun Dis Public Health"},{"key":"9023_CR25","unstructured":"RKI (Robert-Koch-Institut) (2001). Merkbl\u00e4tter f\u00fcr \u00e4rzte. Hepatitis A (aktualisiert). URL: http:\/\/www.rki.de\/cln_011\/ nn_225576\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Rat__HepatitisA, Berlin: Download date 2. August 2005"},{"key":"9023_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-9071(199709)53:1<69::AID-JMV12>3.0.CO;2-S","volume":"53","author":"B Grinde","year":"1997","unstructured":"Grinde B, Stene-Johansen K, Sharma B, Hoel T, Jensenius M, Skaug K, 1997; Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers \u2013 infection by needle sharing? J Med Virol 53: 69\u201375","journal-title":"J Med Virol"},{"key":"9023_CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2893.2004.00503.x","volume":"11","author":"K Roy","year":"2004","unstructured":"Roy K, Howie H, Parry J, Molyneaux P, Goldberg D, Taylor A, 2004; Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: A case\u2013control study J Viral Hepat 11: 277\u2013282","journal-title":"J Viral Hepat"},{"key":"9023_CR28","unstructured":"BAG (Bundesamt f\u00fcr Gesundheit) (2004). Hepatitis-A-F\u00e4lle im Zusammenhang mit Konsumenten von injizierbaren Drogen? Bulletin 6 vom 2. Februar 2004. Bern: 2004"},{"key":"9023_CR29","unstructured":"UNAIDS. 2004 Report on the global AIDS epidemic. URL: http:\/\/www.unaids.org\/bangkok2004\/GAR2004_ html\/GAR2004_00_en.htm, Geneva: 2004. Downlaod date: 2. August 2005"},{"key":"9023_CR30","volume-title":"Der Forschungsverbund station\u00e4re Suchttherapie act-info FOS im Jahr 2004","author":"S Schaaf","year":"2005","unstructured":"Schaaf S; Grichting E; Bolliger H, 2005; Der Forschungsverbund station\u00e4re Suchttherapie act-info FOS im Jahr 2004 Forschungsbericht aus dem Institut f\u00fcr Suchtforschung Nr. 196 Z\u00fcrich"},{"issue":"1","key":"9023_CR31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.91.1.38","volume":"91","author":"VD Hope","year":"2001","unstructured":"Hope VD, Judd A, Hickman M, et al., 2001; Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health 91(1): 38\u201342","journal-title":"Am J Public Health"},{"key":"9023_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0376-8716(01)00196-X","volume":"66","author":"G Vidal-Trecan","year":"2002","unstructured":"Vidal-Trecan G, Varescon-Pousson I, Boissonnas A, 2002; Injection risk behaviors at the first and at the most recent injections among drug users Drug Alcohol Depend 66: 197\u2013109","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl. 1","key":"9023_CR33","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","volume":"18","author":"RS Garfein","year":"1998","unstructured":"Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D, 1998; Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users J Acquir Immune Defic Syndr Hum Retrovirol 18(Suppl. 1): S11\u2013S19","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1","key":"9023_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","volume":"91","author":"T Diaz","year":"2001","unstructured":"Diaz T, Des Jarlais DC, Vlahov D, et al., 2001; Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhatten, New York City Am J Public Health 91(1): 23\u201330","journal-title":"Am J Public Health"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-006-9023-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-006-9023-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-006-9023-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:35:38Z","timestamp":1627605338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-006-9023-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,21]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,10,17]]}},"alternative-id":["9023"],"URL":"https:\/\/doi.org\/10.1007\/s10654-006-9023-z","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,21]]}}}